Ritu Shrestha

4PUBLICATIONS
0CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 15, 2022
CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer.

Lu Cao, Kim R Bridle, Ritu Shrestha

|Jul 02, 2021
Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells.

Ritu Shrestha, Kim R Bridle, Lu Cao

|Jun 02, 2021
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study.

Lu Cao, Prashanth Prithviraj, Ritu Shrestha

|Apr 30, 2021
Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib Treatment.

Ritu Shrestha, Prashanth Prithviraj, Kim R Bridle

Pageof 1

Frequent Collaborators